Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5728098 | Radiología | 2017 | 13 Pages |
Abstract
Prostatic multi-parametric magnetic resonance imaging (MP-MRI) has recently had a wide development becoming a key tool in the diagnostic and therapeutic decisions in prostate cancer (Pca). The fast development both in technology and in reading (PIRADS V2) requires a continuous updating of knowledge within this area. The aim of this article is to present an updated revision of technical aspects, reading patterns and prostatic MP-MRI in Pca, with a multidisciplinary approach. Currently guidelines establish the use of the MP-MRI when there is a high PSA and a negative prostatic biopsy; tumor staging; evaluation in candidates to active surveillance; focal treatments plans and tumoral recurrence evaluation. Although it is used in other indications in some centers, like its use in patients suspicious of Pca but with no previous biopsy, there is still the need of a cost/benefit assessment for its use to be wider.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
V. Catalá, J.C. Vilanova, J.M. Gaya, F. Algaba, T. MartÃ,